Palomino Laboratories Inc. PALX
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.18M | -3.42M | -- | -- | -- |
| Total Depreciation and Amortization | 15.30K | 2.80K | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.75M | 1.08M | -- | -- | -- |
| Change in Net Operating Assets | -32.40K | -64.50K | -- | -- | -- |
| Cash from Operations | -3.44M | -2.40M | -- | -- | -- |
| Capital Expenditure | -1.26M | -318.30K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.26M | -318.30K | -- | -- | -- |
| Total Debt Issued | 0.00 | 1.70M | -- | -- | -- |
| Total Debt Repaid | -352.40K | -352.40K | -- | -- | -- |
| Issuance of Common Stock | 24.58M | 9.76M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.80M | -1.86M | -- | -- | -- |
| Cash from Financing | 22.42M | 9.24M | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.72M | 6.52M | -- | -- | -- |